HP211206
Based on 1 Customer Validation
HP211206 is a bifunctional CRBN-recruiting SARS-CoV-2 Mpro PROTAC degrader with a CRBN IC50 of 3.2 μM and a SARS-CoV-2 Mpro DC50 of 621 nM. HP211206 recruits E3 ubiquitin ligase CRBN to drive ubiquitination and proteasomal degradation of wild-type SARS-CoV-2 Mpro and E166 mutant while inhibiting Mpro enzymatic activity, exhibits no cytotoxicity against normal mammalian cells at tested concentrations, and can be used for the study of COVID-19 and SARS-CoV-2 infection
(Pink: SARS-CoV-2 Mpro ligand (HY-170599); Blue: Cereblon ligand (HY-41547); Black: linker (HY-B0236)).
For research use only. We do not sell to patients.
- CAS No.: 3119106-17-8
- Formula: C42H55F2N9O10
- Molecular Weight:883.94
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
IC50: 181.9 nM (SARS-CoV-2 Mpro);
DC50: 621 nM (SARS-CoV-2 Mpro)[1].
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | DC50 |
621 nM
|
Half-maximum degradation of overexpressed wild-type SARS-CoV-2 Mpro in human HEK 293T cells, determined by grayscale analysis of protein levels after 48 h of treatment with HP211206.
Half-maximum degradation of overexpressed wild-type SARS-CoV-2 Mpro in human HEK 293T cells, determined by grayscale analysis of protein levels after 48 h of treatment with HP211206.
|
38064654 |
In Vitro
HP211206 (1 nM-100 μM; 30 min) strongly inhibits purified SARS-CoV-2 Mpro with an IC50 of 181.9 nM and binds CRBN with an IC50 of 3.2 μM[1].
HP211206 (3 nM-10 μM; 2-48 h) induces time- and dose-dependent degradation of wild-type SARS-CoV-2 Mpro in HEK 293T cells, with a DC50 of 621 nM[1].
HP211206 (10-3000 nM; 2-48 h) induces dose-dependent degradation of drug-resistant SARS-CoV-2 Mpro mutants SARS-CoV-2 MproE166V and SARS-CoV-2 MproE166A in HEK 293T cells[1].
HP211206 (3 nM-10 μM; 2-48 h) dose-dependently and time-dependently degrades SARS-CoV-2 Mpro in transfected HEK 293T cells[1].
HP211206 (Serially diluted concentrations; 3 h) binds to GST-tagged wild-type human Cereblon with an IC50 of 3.2 μM[1].
HP211206 (0.1-100 μM; 48 h) shows no significant cytotoxicity in HEK 293T cells at concentrations up to 100 μM after 48 h of incubation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK 293T cells
-
Concentration:0.1-100 μM
-
Incubation Time:48 h
-
Result:Showed no significant cytotoxicity at all tested concentrations.
-
Cell Line:HEK 293T cells transfected with pcDNA3.1(+)-SARS-CoV-2 Mpro plasmid
-
Concentration:1000 nM
-
Incubation Time:2, 6, 12, 24, 36, 48 h
-
Result:Induced degradation of transfected SARS-CoV-2 Mpro in time-dependent manners.
-
Cell Line:HEK 293T cells transfected with pcDNA3.1(+)-SARS-CoV-2 Mpro plasmid
-
Concentration:3, 10, 30, 100, 300, 1000, 3000,10000 nM
-
Incubation Time:48 h
-
Result:Induced degradation of transfected SARS-CoV-2 Mpro in dose-dependent manners.
Chemical Information
-
CAS No. 3119106-17-8
-
Appearance Solid
-
Molecular Weight 883.94
-
Formula C42H55F2N9O10
-
Color Light yellow to green yellow
-
SMILES
O=C(CCC1N2C(C(C(NCCCCCC(N(C)[C@@H](C)C(N[C@@H](C(C)(C)C)C(N3[C@H](C(N[C@H](C#N)C[C@H]4C(NCC4)=O)=O)C[C@@H](OC(F)F)C3)=O)=O)=O)=CC=C5)=C5C2=O)=O)NC1=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)